Insider digest · BMY
Bristol Myers Squibb insider filings, Nov 4, 2026
Bristol Myers Squibb insiders filed 1 routine Form 4 report on Nov 4, 2026: tax withholding, exercises. None of them was a purchase or a sale in the market. This page groups them in one place; each row links to the filing note, and each number links to the Form 4 itself.
What the codes mean: how to read a Form 4 · stock-based compensation.
Shares withheld for taxes
Shares the company kept back to cover taxes (or the exercise price) when awards vested. This is not a sale in the market. Total for the day: 3,848 shares or units, worth about $237,460 at the prices reported.
| Person | Code | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Adam Lenkowsky · EVP, Chief Commercial Officer | F | Common Stock, $0.10 par value | 3,848 | $61.71 | $237,460 | 23,380 |
Exercises and conversions
Options exercised or units converted into shares. Total for the day: 15,044 shares or units.
| Person | Code | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Adam Lenkowsky · EVP, Chief Commercial Officer | M | Common Stock, $0.10 par value | 7,522 | – | – | 27,228 |
| Adam Lenkowsky · EVP, Chief Commercial Officer | M | Restricted Stock Units | 7,522 | – | – | 15,046 |
The filings
- Bristol Myers Squibb Chief Commercial Officer Adam Lenkowsky reports exercising or converting 7,522 shares · SEC filing index
Bristol Myers Squibb company file → · All Bristol Myers Squibb filings notes
Disclosures
- Editor holdings in BMY
- The editor holds no position in Bristol Myers Squibb (BMY). As of Nov 11, 2026.
- Compensation
- Nobody paid for this page. No affiliate links.
A summary of public filings for general education, the same for every reader. Not a recommendation to buy, sell or hold BMY.